4-(furan-2-carbonyl)-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

3-Amino-3-cyclopentylpropan-1-ol, 97%, 100mg

3,5-Dibromopyridine-4-carbaldehyde, 95.0%, 250g

3,4-Dimethoxybenzylamine, 96.0%, 25g

3,5-Dibromo-2-(trifluoromethyl)pyridin-4-amine, 10g

4-[2-(2-Hydroxyethoxy)ethyl]morpholine, 97.0%, 1g

D-luciferin sodium salt, min 99%, for biochemistry, 10 mg, glass packaging

1-Boc-Azetidine-3-carboxylic acid, 97.0%, 1g

Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride, 95.0%, 100mg

4-(Dimethylamino)butanoic acid, 97%, 5g

2-{3-oxo-2h,3h-[1,2,4]triazolo[4,3-a]pyridin-2-yl}acetonitrile, 95%, 10g

1-Bromo-2-fluoro-4,5-dimethylbenzene, 95.0%, 500mg

(2R)-1-(11bR)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,2,3,4-tetrahydro-2-methylquinoline, 97%, 250mg